Found: 2
Select item for more details and to access through your institution.
Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4625, doi. 10.3390/cancers13184625
- By:
- Publication type:
- Article
Targeting of the NOX1/ADAM17 Enzymatic Complex Regulates Soluble MCAM-Dependent Pro-Tumorigenic Activity in Colorectal Cancer.
- Published in:
- Biomedicines, 2023, v. 11, n. 12, p. 3185, doi. 10.3390/biomedicines11123185
- By:
- Publication type:
- Article